Described herein are pharmaceutical packaging units which reduce oxidative degradation of morphine, hydromorphone, promethazine along with other oxygen-sensitive medicines, such systems which include a syringe having an oxygen permeable tip cap, a hermetically sealed oxygen barrier blister packaging